Healthcare Equipment and Supplies
Company Overview of Integrated Diagnostics Inc.
Integrated Diagnostics Inc. engages in developing and creating laboratory-developed blood-based molecular diagnostics tools that assist physicians with the early diagnosis of complex diseases with a non-invasive blood test, such as lung cancer by simultaneously monitoring disease molecular markers. It offers Xpresys Lung, a molecular blood test to provide non-invasive objective information for the assessment of pulmonary nodules. Integrated Diagnostics Inc. has a strategic partnership with Agilent Technologies Inc. The company was formerly known as Homestead Clinical Corporation. Integrated Diagnostics Inc. was founded in 2005 and is based in Seattle, Washington.
219 Terry Avenue North
Seattle, WA 98109-5208
Founded in 2005
Key Executives for Integrated Diagnostics Inc.
Chief Executive Officer and Board Member
Co-Founder and Scientific Advisor
Co-Founder and Board Member
Compensation as of Fiscal Year 2014.
Integrated Diagnostics Inc. Key Developments
Integrated Diagnostics Appoints Douglas Sanders as Chief Financial Officer
Jan 8 15
Integrated Diagnostics appointed Douglas Sanders as chief financial officer. Sanders is a prominent international life sciences CFO and entrepreneur who most recently served as CFO of CMC Biologics. In addition to his leadership role at CMC Biologics, Sanders is the co-founder of several life sciences companies. Prior to that, he spent 15 years with Hoffmann-La Roche, mainly in Europe. His most recent position at Roche was as head of business operations and CFO for Roche Consumer Health, a division of Hoffmann-La Roche based in Switzerland.
Integrated Diagnostics Secures Contracts for Xpresys(R) Lung With Multiplan and Five Other PPOs
Nov 5 14
Integrated Diagnostics announced that it has secured contractual agreements with MultiPlan and five other PPOs (preferred provider organizations) for Xpresys(R) Lung, the first non-invasive molecular blood test for the assessment of pulmonary nodules. The other PPOs are: FedMed, Fortified Provider Network, InterWest Health, Stratose, and Three Rivers Provider Network. Together, these managed care organizations provide access to more than 130 million insured lives; combined with Indi's existing commercial insurance contracts the test is now available to well over 200 million insured lives. Xpresys Lung is a breakthrough protein expression blood test developed to provide physicians with a solution to a major medical dilemma in the United States -- the overtreatment of benign lung nodules. Xpresys Lung provides physicians with objective information to identify nodules with a high probability of being benign, potentially reducing unnecessary invasive procedures which may be risky for the patient and costly to the healthcare system.
Integrated Diagnostics Inc. Presents at Baird's 2014 Healthcare Conference, Sep-04-2014 11:25 AM
Sep 1 14
Integrated Diagnostics Inc. Presents at Baird's 2014 Healthcare Conference, Sep-04-2014 11:25 AM. Venue: The New York Palace, New York, New York, United States.
Similar Private Companies By Industry
Recent Private Companies Transactions
April 25, 2014
Most Searched Private Companies
Sponsored Financial Commentaries